Douglas Nixon, M.D., Ph.D., chair of the Department of Microbiology, Immunology, and Tropical Medicine, was featured in Infection Control Today for his recently published research on an antibody that can neutralize the HIV-1 fossil virus, published in the Cutting-edge Section of the Journal of Immunology. He was also featured in BioPortfolio, Health Medicine Network, Jersey Tribune, Medical Xpress, Science Codex, Science Daily, and Fierce BioTech Research.
Infection Control Today - GW Researcher Unlocks Next Step in Creating HIV-1 Immunotherapy Using Fossil Virus
Latest News
Basil Considine, a third-year medical student at the George Washington University School of Medicine and Health Sciences (GW SMHS), addressed U.S. Food and Drug Administration (FDA) leadership, pharmaceutical representatives, and association stakeholders during a public meeting regarding the…
The George Washington University School of Medicine and Health Sciences (SMHS) recently honored a pair of accomplished faculty members, Sharad Goyal, MD, and Christina M. Puchalski, MD ’94, RESD ’97, for their academic excellence and leadership in patient care by formally bestowing them with…
The GW Department of Dermatology has been awarded a prestigious Competitive Clinical Research Grant by Eli Lilly and Company to evaluate the effectiveness of Atopic Triad (atopic dermatitis, asthma, and seasonal allergies) screening and education to reduce the burden of Atopic Dermatitis and its…